225 related articles for article (PubMed ID: 15105097)
21. Neonatal meningitis due of Escherichia coli K1.
Glode MP; Sutton A; Robbins JB; McCracken GH; Gotschlich EC; Kaijser B; Hanson LA
J Infect Dis; 1977 Aug; 136 Suppl():S93-7. PubMed ID: 330780
[TBL] [Abstract][Full Text] [Related]
22. Coexpression of colanic acid and serotype-specific capsular polysaccharides in Escherichia coli strains with group II K antigens.
Keenleyside WJ; Bronner D; Jann K; Jann B; Whitfield C
J Bacteriol; 1993 Oct; 175(20):6725-30. PubMed ID: 8407850
[TBL] [Abstract][Full Text] [Related]
23. The Role of Iron in the Susceptibility of Neonatal Mice to Escherichia coli K1 Sepsis.
Michels KR; Lambrecht NJ; Carson WF; Schaller MA; Lukacs NW; Bermick JR
J Infect Dis; 2019 Aug; 220(7):1219-1229. PubMed ID: 31136646
[TBL] [Abstract][Full Text] [Related]
24. Evaluation of immunotherapeutic approaches for the potential treatment of infections caused by K1-positive Escherichia coli.
Cross AS; Zollinger W; Mandrell R; Gemski P; Sadoff J
J Infect Dis; 1983 Jan; 147(1):68-76. PubMed ID: 6401788
[TBL] [Abstract][Full Text] [Related]
25. The importance of the K1 capsule in invasive infections caused by Escherichia coli.
Cross AS; Gemski P; Sadoff JC; Orskov F; Orskov I
J Infect Dis; 1984 Feb; 149(2):184-93. PubMed ID: 6199436
[TBL] [Abstract][Full Text] [Related]
26. Role of the capsule and the O antigen in resistance of O18:K1 Escherichia coli to complement-mediated killing.
Pluschke G; Mayden J; Achtman M; Levine RP
Infect Immun; 1983 Dec; 42(3):907-13. PubMed ID: 6196296
[TBL] [Abstract][Full Text] [Related]
27. Genetic analysis of Escherichia coli K1 gastrointestinal colonization.
Martindale J; Stroud D; Moxon ER; Tang CM
Mol Microbiol; 2000 Sep; 37(6):1293-305. PubMed ID: 10998163
[TBL] [Abstract][Full Text] [Related]
28. Escherichia coli in bacteremia: O-acetylated K1 strains appear to be more virulent than non-O-acetylated K1 strains.
Frasa H; Procee J; Torensma R; Verbruggen A; Algra A; Rozenberg-Arska M; Kraaijeveld K; Verhoef J
J Clin Microbiol; 1993 Dec; 31(12):3174-8. PubMed ID: 7508454
[TBL] [Abstract][Full Text] [Related]
29. Induction of bacteremia in newborn rats by Escherichia coli K1 is correlated with only certain O (lipopolysaccharide) antigen types.
Pluschke G; Mercer A; Kusećek B; Pohl A; Achtman M
Infect Immun; 1983 Feb; 39(2):599-608. PubMed ID: 6187683
[TBL] [Abstract][Full Text] [Related]
30. Epidemiology of Escherichia coli K1 in healthy and diseased newborns.
Sarff LD; McCracken GH; Schiffer MS; Glode MP; Robbins JB; Orskov I; Orskov F
Lancet; 1975 May; 1(7916):1099-104. PubMed ID: 49468
[TBL] [Abstract][Full Text] [Related]
31. Selective synthesis and labeling of the polysialic acid capsule in Escherichia coli K1 strains with mutations in nanA and neuB.
Vimr ER
J Bacteriol; 1992 Oct; 174(19):6191-7. PubMed ID: 1400168
[TBL] [Abstract][Full Text] [Related]
32. Bacteriophage K1-5 encodes two different tail fiber proteins, allowing it to infect and replicate on both K1 and K5 strains of Escherichia coli.
Scholl D; Rogers S; Adhya S; Merril CR
J Virol; 2001 Mar; 75(6):2509-15. PubMed ID: 11222673
[TBL] [Abstract][Full Text] [Related]
33. Host factors in the resistance of newborn mice to K1 Escherichia coli infection.
Pluschke G; Pelkonen S
Microb Pathog; 1988 Feb; 4(2):93-102. PubMed ID: 3059139
[TBL] [Abstract][Full Text] [Related]
34. A tale of tails: Sialidase is key to success in a model of phage therapy against K1-capsulated Escherichia coli.
Bull JJ; Vimr ER; Molineux IJ
Virology; 2010 Mar; 398(1):79-86. PubMed ID: 20006993
[TBL] [Abstract][Full Text] [Related]
35. The K1 capsular polysaccharide of Escherichia coli.
Silver RP; Aaronson W; Vann WF
Rev Infect Dis; 1988; 10 Suppl 2():S282-6. PubMed ID: 3055198
[TBL] [Abstract][Full Text] [Related]
36. The capsule supports survival but not traversal of Escherichia coli K1 across the blood-brain barrier.
Hoffman JA; Wass C; Stins MF; Kim KS
Infect Immun; 1999 Jul; 67(7):3566-70. PubMed ID: 10377140
[TBL] [Abstract][Full Text] [Related]
37. The K1 capsule modulates trafficking of E. coli-containing vacuoles and enhances intracellular bacterial survival in human brain microvascular endothelial cells.
Kim KJ; Elliott SJ; Di Cello F; Stins MF; Kim KS
Cell Microbiol; 2003 Apr; 5(4):245-52. PubMed ID: 12675682
[TBL] [Abstract][Full Text] [Related]
38. Logarithmic phase Escherichia coli K1 efficiently avoids serum killing by promoting C4bp-mediated C3b and C4b degradation.
Wooster DG; Maruvada R; Blom AM; Prasadarao NV
Immunology; 2006 Apr; 117(4):482-93. PubMed ID: 16556262
[TBL] [Abstract][Full Text] [Related]
39. Contribution of capsular polysaccharide and surface properties to virulence of Escherichia coli K1.
Allen PM; Roberts I; Boulnois GJ; Saunders JR; Hart CA
Infect Immun; 1987 Nov; 55(11):2662-8. PubMed ID: 3312006
[TBL] [Abstract][Full Text] [Related]
40. The rcsA gene of Escherichia coli O9:K30:H12 is involved in the expression of the serotype-specific group I K (capsular) antigen.
Keenleyside WJ; Jayaratne P; MacLachlan PR; Whitfield C
J Bacteriol; 1992 Jan; 174(1):8-16. PubMed ID: 1729226
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
